<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">Health</journal-id><journal-title-group><journal-title>Health</journal-title></journal-title-group><issn pub-type="epub">1949-4998</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/health.2020.122014</article-id><article-id pub-id-type="publisher-id">Health-98297</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject><subject> Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Practical Guidance for Non-Specialist Physical Therapists Managing People with Hemophilia and Musculoskeletal Complications
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Angela</surname><given-names>Forsyth</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Greig</surname><given-names>Blamey</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Sébastien</surname><given-names>Lobet</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Paul</surname><given-names>McLaughlin</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib></contrib-group><aff id="aff3"><addr-line>Cliniques Universitaires Saint-Luc, Service d’Hématologie, Brussels, Belgium</addr-line></aff><aff id="aff4"><addr-line>Hemophilia Centre and Thrombosis Unit, Royal Free London, London, UK</addr-line></aff><aff id="aff1"><addr-line>REBUILD Program, Diplomat Specialty Infusion Group, Cincinnati, OH, USA</addr-line></aff><aff id="aff2"><addr-line>Manitoba Inherited Bleeding Disorders Program, Health Sciences Center, Winnipeg, MB, Canada</addr-line></aff><pub-date pub-type="epub"><day>21</day><month>01</month><year>2020</year></pub-date><volume>12</volume><issue>02</issue><fpage>158</fpage><lpage>179</lpage><history><date date-type="received"><day>16,</day>	<month>December</month>	<year>2019</year></date><date date-type="rev-recd"><day>14,</day>	<month>February</month>	<year>2020</year>	</date><date date-type="accepted"><day>17,</day>	<month>February</month>	<year>2020</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  People with hemophilia (PWH) have impaired blood coagulation and hemostasis. Bleeding into joints and muscles is the main manifestation of the disorder, causing severe joint damage and muscle complications. Lifelong, regular physical therapy is therefore important for PWH, in order to support recovery from bleeds and reduce recurrences. Ideally, these individuals should be in the care of a hemophilia treatment center (HTC), where a physical therapist (PT) should be a regular part of the comprehensive team. However, not all PWH have convenient access to an HTC, and they may be referred to local non-specialist PTs, who may have only limited experience with the condition, for day-to-day physical therapy treatment. This article, written by four experienced hemophilia PTs, introduces key aspects of the pathology of the hemophilic joint in adult PWH with musculoskeletal complications or established joint disease (or those with inhibitors) that are relevant to PTs. The characteristic differences between the joints of PWH and those of people with similar pathologies are clarified. Practical advice on how the physical therapy consultation can be adjusted for PWH is given, and the importance of communicating with the HTC emphasized. The aim of this narrative review is to raise awareness of hemophilia and joint disease for non-specialist PTs, and serve as helpful background information for PTs who encounter PWH with musculoskeletal complications or established joint disease in their clinics.
 
</p></abstract><kwd-group><kwd>Hemophilia</kwd><kwd> Joint Diseases</kwd><kwd> Physical Therapy</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction and Aims</title><p>Hemophilia A and B are inherited disorders characterized by deficient or missing coagulation factors VIII or IX, respectively, of which the main long-term clinical manifestation is joint damage [<xref ref-type="bibr" rid="scirp.98297-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref2">2</xref>]. People with hemophilia (PWH) have joint and muscle bleeding that results in arthropathy, joint destruction, pain, limited range of motion (ROM), and muscle weakness, which in turn affect functional mobility, balance, posture, and strength [<xref ref-type="bibr" rid="scirp.98297-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref4">4</xref>]. Physical therapy may be helpful to preserve or improve the joint mobility, function, and muscle strength of PWH [<xref ref-type="bibr" rid="scirp.98297-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref6">6</xref>].</p><p>Where available, the main pharmaceutical treatment for hemophilia is clotting factor replacement therapy—the intravenous infusion of factor VIII or IX concentrate, to replace the missing or reduced coagulation factor [<xref ref-type="bibr" rid="scirp.98297-ref3">3</xref>]. Prophylactic treatment can be used to prevent bleeding for people with severe hemophilia; adherence to the prescribed infusion schedule is important, in order to maintain factor concentrations at clinically effective levels and avoid musculoskeletal complications [<xref ref-type="bibr" rid="scirp.98297-ref7">7</xref>]. However, the availability of pharmaceutical treatment is not equal worldwide. On-demand treatment, which aims to treat a bleed after symptoms have appeared, is more prevalent when resources are scarce [<xref ref-type="bibr" rid="scirp.98297-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref3">3</xref>]. Older PWH are also more likely to have been treated on-demand historically, and are therefore more likely to have musculoskeletal complications caused by bleeding into their joints [<xref ref-type="bibr" rid="scirp.98297-ref8">8</xref>].</p><p>Ideally, PWH should have a link to a hemophilia treatment center (HTC), where a multidisciplinary team (typically including a hematologist, nurse, physical therapist [PT], and psychosocial professional) provides comprehensive care to address issues related to the bleeding disorder [<xref ref-type="bibr" rid="scirp.98297-ref7">7</xref>]. However, there is regional variability in the provision of HTCs, such that they may not be easily accessible to all PWH [<xref ref-type="bibr" rid="scirp.98297-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref10">10</xref>]. Indeed, due to geographical, financial or other constraints, considerable numbers of PWH are not regularly cared for in an HTC [<xref ref-type="bibr" rid="scirp.98297-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref10">10</xref>]. Therefore, some PWH who need frequent physical therapy may be more conveniently served in their local community. In these cases, PWH may be referred to providers with limited experience in hemophilia [<xref ref-type="bibr" rid="scirp.98297-ref7">7</xref>].</p><p>This article is the result of the authors’ pooled specialist hemophilia experience totaling 77 years. It aims to provide practical advice for PTs who may be specialists in orthopedics, rheumatology or other areas, but who do not have experience treating adult PWH and who therefore may not be familiar with the nuances of the disorder. We focus specifically on adult PWH with musculoskeletal issues and established joint disease (hereafter simply referred to as “PWH”), and those patients with inhibitors. Younger individuals and those without musculoskeletal issues may have a different profile, due to availability of earlier and more consistent prophylactic treatment [<xref ref-type="bibr" rid="scirp.98297-ref8">8</xref>], and are therefore considered outside the scope of this review. Although many of the same principles apply when treating the general population, there are important differences and considerations in hemophilia. We discuss these aspects, describe joint pathology in PWH, and provide practical guidance for managing these individuals. These are important topics for non-specialist PTs, as having an awareness of the main issues affecting joints in hemophilia builds PWH’s confidence and trust that the physical therapy treatment will not cause a bleed.</p></sec><sec id="s2"><title>2. Musculoskeletal Bleeding and the Joint in the Adult with Hemophilia</title><p>Musculoskeletal bleeding episodes, including hemarthrosis (joint bleeding), make up approximately 80% of all bleeds in PWH and can cause a high degree of joint damage and functional limitations if there is no rehabilitation [<xref ref-type="bibr" rid="scirp.98297-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref6">6</xref>]. All synovial joints have the potential for hemarthrosis, and bleeding into the intra-articular joint space occurs when capillaries in the inner layer of the synovial lining leak blood into the space as a result of vessel injury [<xref ref-type="bibr" rid="scirp.98297-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref11">11</xref>]. This injury may result from local trauma, repetitive stress, or a simple movement affecting the synovial membrane [<xref ref-type="bibr" rid="scirp.98297-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref11">11</xref>]. Even a single hemarthrosis can set a process in motion that results in joint disease later in life, but the risk of joint damage increases with each subsequent hemarthrosis [<xref ref-type="bibr" rid="scirp.98297-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref11">11</xref>].</p><p>Acute hemarthrosis in PWH presents as a burning or tingling sensation in the joint, which progresses to an inflamed joint that becomes tense and warm to the touch, along with pain and a reduced ROM, as well as possible erythema of the skin (<xref ref-type="fig" rid="fig1">Figure 1</xref>(a)) [<xref ref-type="bibr" rid="scirp.98297-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref12">12</xref>]. As treatment strategy is dependent on the type of hemarthrosis, and symptoms may be similar, differential diagnosis is critical.</p><p>Joint hemarthroses cause both direct and indirect damage to the synovial membrane and cartilage (<xref ref-type="fig" rid="fig2">Figure 2</xref>) [<xref ref-type="bibr" rid="scirp.98297-ref1">1</xref>]. Acute synovitis (inflammation of the synovial membrane) can become chronic, and hypertrophy of the membrane, which is generally palpable, may lead to easily triggered sub-acute hemarthroses [<xref ref-type="bibr" rid="scirp.98297-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref12">12</xref>]. These typically present with tolerable pain and minor joint immobility [<xref ref-type="bibr" rid="scirp.98297-ref12">12</xref>]. Joints that are affected by repeated bleeding (“target joints”) should be monitored closely to avoid permanent damage [<xref ref-type="bibr" rid="scirp.98297-ref2">2</xref>]. Monitoring strategies used by the authors of this article include adherence to hemophilia medical treatment as well as functional and physical performance assessment, and imaging techniques such as ultrasound. Joint health can also be monitored with the Hemophilia Joint Health Score (HJHS) [<xref ref-type="bibr" rid="scirp.98297-ref13">13</xref>], although this is quite a complex tool that should only be used by PTs trained in its use.</p><p>Repeated hemarthroses in target joints hinder recovery of ROM and muscle strength [<xref ref-type="bibr" rid="scirp.98297-ref2">2</xref>]. They can also trigger multiple episodic joint swelling [<xref ref-type="bibr" rid="scirp.98297-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref14">14</xref>], which causes changes within the joint and may be one of the key reasons for poor proprioception and joint awareness, unless the person undergoes rehabilitation at each occurrence [<xref ref-type="bibr" rid="scirp.98297-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref6">6</xref>]. Importantly, PWH may also have sub-clinical bleeding episodes that, although not detectable by them or their PT on physical examination, can also cause joint damage over time, due to exposure of the structures to blood [<xref ref-type="bibr" rid="scirp.98297-ref15">15</xref>].</p><p>Blood in joints results in chondrocyte death, causing cartilage matrix degradation and permanent cartilage and bone degeneration, ultimately giving rise to</p><p>hemophilic arthropathy—joint disease caused by bleeding in PWH (<xref ref-type="fig" rid="fig1">Figure 1</xref>(b)) [<xref ref-type="bibr" rid="scirp.98297-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref11">11</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref16">16</xref>] —and causing persistent pain in the joint [<xref ref-type="bibr" rid="scirp.98297-ref12">12</xref>]. Polyarthropathy may also develop from frequent hemarthroses in multiple joints, even with appropriate and adequate factor concentrate management and access to specialized hemophilia care and physical therapy. In such cases, physical therapy aims to improve joint mobilization and help prevent further soft tissue fibrosis or contracture and muscle atrophy [<xref ref-type="bibr" rid="scirp.98297-ref14">14</xref>].</p><p>Elective orthopedic surgery, including joint replacement, is frequently performed in PWH with established joint disease to reduce pain and disability [<xref ref-type="bibr" rid="scirp.98297-ref17">17</xref>]. Such surgery, which is challenging because of the extent of pre-existing joint damage [<xref ref-type="bibr" rid="scirp.98297-ref18">18</xref>], should be undertaken by an experienced multidisciplinary team in the HTC setting, in order to achieve optimal outcomes [<xref ref-type="bibr" rid="scirp.98297-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref19">19</xref>]. During the post-operative period, hemostatic coverage must be ensured with an adequate clotting factor replacement regimen [<xref ref-type="bibr" rid="scirp.98297-ref7">7</xref>]. Physical therapy and rehabilitation is recommended post-surgery, but input from the HTC team is required [<xref ref-type="bibr" rid="scirp.98297-ref7">7</xref>].</p><p>In people with hemophilic arthropathy and those recovering from surgery, physical therapy intervention can address muscle strength, maintain joint mobilization and function, and play an important role in both prevention of and recovery from hemarthroses [<xref ref-type="bibr" rid="scirp.98297-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref20">20</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref21">21</xref>].</p></sec><sec id="s3"><title>3. Adults with Hemophilia and Musculoskeletal Complications</title><p>The level of joint damage present in PWH varies worldwide, depending on the individual person’s ability to receive adequate treatment or other variables that result in poorly managed bleeding. Additionally, some PWH develop antibodies against the clotting factor (“inhibitors”), and bleeding and joint disease can be more severe than usual in these patients [<xref ref-type="bibr" rid="scirp.98297-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref24">24</xref>]. In our experience, PWH may therefore have a higher degree of joint damage than expected, and PTs who do not have experience treating PWH may not have encountered this in other practice areas. PWH may have a greater level of joint damage present at a younger age than other patients (e.g. those with rheumatoid arthritis), and frequently in multiple joints. Early cartilage damage in the joint is initiated by bleeding, with most children with severe hemophilia having their first joint bleed by 4 years of age [<xref ref-type="bibr" rid="scirp.98297-ref25">25</xref>]. However, function may be better than expected, and PWH can still benefit from therapeutic intervention. It is important to assess all joints and establish a baseline for their functional mobility before starting a rehabilitation program. When designing the physical therapy or rehabilitation program, an awareness of global joint involvement and a risk vs benefit analysis of all chosen assessment and intervention techniques is critical in order to avoid triggering bleeding episodes.</p><p>As a consequence of long-lasting severe joint disease, PWH are likely to experience a chronic, baseline level of pain in multiple joints [<xref ref-type="bibr" rid="scirp.98297-ref26">26</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref27">27</xref>]. Additionally, they may have acute pain layered on top of chronic pain when there is bleeding or a flare in arthropathy symptoms [<xref ref-type="bibr" rid="scirp.98297-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref28">28</xref>]. Baseline pain in PWH may be higher than that in the general population due to multiple arthrophic joints and advanced joint damage, but some individuals may show better acceptance of chronic pain from living with multiple affected joints [<xref ref-type="bibr" rid="scirp.98297-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref29">29</xref>]. To assess problematic pain, PTs can use standardized questionnaires and scales [<xref ref-type="bibr" rid="scirp.98297-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref30">30</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref31">31</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref32">32</xref>]. When taking a medication history in PWH, it is important to understand that some medications and herbal supplements can impede the coagulation process and are therefore strictly contraindicated (for example acetylsalicylic acid or St John’s wort [<xref ref-type="bibr" rid="scirp.98297-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref33">33</xref>]). PTs should be aware that some PWH may have access to pain medications prescribed for them by other practitioners, or may be taking over the counter pain medication, without input from the HTC. Therefore, PTs need to have a working knowledge of which pain medications and herbal supplements may adversely affect factor treatment or bleeding complications, and are therefore contraindicated for PWH. The HTC can advise and provide guidance to PTs on this.</p><p>Perception of pain may vary between individuals with hemophilia: often, older individuals may have become accustomed to baseline levels of pain, but pain may peak during bleeding events, especially major bleeding events [<xref ref-type="bibr" rid="scirp.98297-ref27">27</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref32">32</xref>]. It is important to prioritize the most troublesome pain when seeing PWH, and to understand that it is unlikely they will become pain-free. PTs should discuss pain with PWH similarly to how they would counsel people with chronic pain in the general population: the emphasis should be on management rather than treatment, and on meeting goals that are not purely focused on reducing or eliminating pain.</p><p>Owing to musculoskeletal bleeding complications and joint damage, balance impairments, proprioception issues and reduced muscle strength may have accumulated over a lifetime [<xref ref-type="bibr" rid="scirp.98297-ref34">34</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref36">36</xref>]. For example, many older PWH may have had long periods of immobility or joint immobilization in their growing years [<xref ref-type="bibr" rid="scirp.98297-ref17">17</xref>], which likely influenced the development of their motor co-ordination strategies [<xref ref-type="bibr" rid="scirp.98297-ref35">35</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref37">37</xref>]. Changes of the joint articulation surfaces may, in time, affect balance and dynamic stability [<xref ref-type="bibr" rid="scirp.98297-ref38">38</xref>]. Therefore, it is the authors’ opinion that balance issues need to be monitored and treated regularly and carefully, as they may persist if not managed properly. PTs can provide adaptive strategies and equipment to maintain and improve function despite joint changes.</p><p>Hematomas can also affect muscle strength, and may lead to shortening of the muscle due to fibrosis [<xref ref-type="bibr" rid="scirp.98297-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref21">21</xref>]. Maintaining adequate strength is important to provide dynamic stability to the joints to aid in the prevention of hemarthroses [<xref ref-type="bibr" rid="scirp.98297-ref21">21</xref>]. It is our opinion that physical therapy intervention is unlikely to be able to return strength to levels associated with people without hemophilia, as PWH may have had years of muscle atrophy and contractures. However, the PT can still work towards and encourage a state of wellness by carefully planning individualized, supervised exercise programs (which may include strength, flexibility and cardiovascular exercises), even if there is advanced joint disease or poor joint health or function [<xref ref-type="bibr" rid="scirp.98297-ref39">39</xref>]. Indeed, fitness and wellness benefits were observed in a study after a six-week exercise program in PWH, including in individuals with complications and co-infections [<xref ref-type="bibr" rid="scirp.98297-ref39">39</xref>]. However, timelines for progress and treatment protocols typically used in the general population are generally not suitable in PWH. Programs for PWH should consider the joint- and muscle-status of the individual, and therefore should start conservatively, be pain-free for the individual, and intensify only when previous exercises have been tolerated successfully [<xref ref-type="bibr" rid="scirp.98297-ref39">39</xref>]. Furthermore, the positive effects of individualized exercise on wellbeing have also been shown in other conditions that are often comorbid with hemophilia, such as HIV infection. In one such study, patients with HIV showed improvements in physical function and quality of life after a 10-week exercise and wellbeing program [<xref ref-type="bibr" rid="scirp.98297-ref40">40</xref>].</p><p>PWH may have adapted to their arthropathy and therefore present with features that are characteristic of hemophilia joint damage. The unique, characteristic posture of some PWH (see <xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="fig" rid="fig3">Figure 3</xref>) is caused by multiple joint involvement and soft tissue contractures that are not always possible to correct [<xref ref-type="bibr" rid="scirp.98297-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref41">41</xref>]. Likewise, PWH may develop an unusual gait to compensate for multiple arthrophic joints, in order to achieve the most efficient way of walking [<xref ref-type="bibr" rid="scirp.98297-ref42">42</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref43">43</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref44">44</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref45">45</xref>]. Trying to force a textbook posture, such as a neutral hip position, or gait change, such as heel strike, may be detrimental as it may place further stress on other affected joints and soft tissue and may cause bleeding complications. It may be useful to observe how PWH have adapted: how they move, their footwear, the differing heights of their crutches to accommodate</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Adaptive postures and positions of comfort for PWH following joint bleeds (and one muscle bleed)</title></caption><table><tbody><thead><tr><th align="center" valign="middle"  rowspan="2"  >Bleeds</th><th align="center" valign="middle"  colspan="3"  >Adaptive postures and position of comfort</th></tr></thead><tr><td align="center" valign="middle" >Position of comfort</td><td align="center" valign="middle" >Habitual posture</td><td align="center" valign="middle" >Potential problems</td></tr><tr><td align="center" valign="middle" >Knee<sup>a</sup><sup> </sup></td><td align="center" valign="middle" >Flexion</td><td align="center" valign="middle" >Walking on flexed knee, with hip flexed and/or ankle plantarflexed to compensate</td><td align="center" valign="middle" >Pain in patellofemoral joint; stress on ankle; overuse of hamstrings; weak quadriceps</td></tr><tr><td align="center" valign="middle" >Elbow<sup>a</sup><sup> </sup></td><td align="center" valign="middle" >Flexion</td><td align="center" valign="middle" >Loss of elbow extension, arm may be carried with shoulder extended</td><td align="center" valign="middle" >Eventual difficulty with forward elevation of the arm</td></tr><tr><td align="center" valign="middle" >Ankle<sup>a</sup><sup> </sup></td><td align="center" valign="middle" >Plantarflexion</td><td align="center" valign="middle" >Walking on toes, with knee and/or hip flexed to compensate</td><td align="center" valign="middle" >Ankle in unstable position, with small area of weight-bearing on talus and sole of foot; overuse of calf muscles; pressure on knee</td></tr><tr><td align="center" valign="middle" >Hip (unusual site)<sup>a </sup></td><td align="center" valign="middle" >Flexion, external rotation</td><td align="center" valign="middle" >Hip flexed, increased lumbar lordosis, compensatory knee flexion</td><td align="center" valign="middle" >Incomplete hip extension during gait; compensation with increased rotation of pelvis or spine</td></tr><tr><td align="center" valign="middle" >Shoulder<sup>a</sup><sup> </sup></td><td align="center" valign="middle" >Adduction, internal rotation</td><td align="center" valign="middle" >Arm held close to body</td><td align="center" valign="middle" >Difficulty with activities related to daily living and self-care</td></tr><tr><td align="center" valign="middle" >Wrist and fingers<sup>a</sup><sup> </sup></td><td align="center" valign="middle" >Flexion</td><td align="center" valign="middle" >Wrist flexed, hand closed</td><td align="center" valign="middle" >Difficulty extending wrist and fingers; inefficient grip</td></tr><tr><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Toes<sup>a</sup><sup> </sup></td><td align="center" valign="middle" >Extension (dorsiflexion)</td><td align="center" valign="middle" >Extension (dorsiflexion)</td><td align="center" valign="middle" >Difficulty wearing shoes</td></tr><tr><td align="center" valign="middle" >Hip flexor (iliopsoas)<sup>b </sup></td><td align="center" valign="middle" >Hip flexion, some external rotation and increased lumbar lordosis</td><td align="center" valign="middle" >Hip flexed, extreme lordosis, walking on toes</td><td align="center" valign="middle" >Back pain; incomplete hip extension; stress on knee and ankle</td></tr></tbody></table></table-wrap><p><sup>a</sup>Adaptive postures and position of comfort for joint bleeds. <sup>b</sup>The adaptive posture and position of comfort for iliopsoas bleeds is also shown; this is an important muscle bleed that is commonly worsened with physical therapy if proper precautions are not taken. This table does not constitute a complete list of the bleeds that may lead to movement restrictions and/or adaptive postures in PWH; several muscle bleeds have been omitted for brevity. Adapted with permission from: <xref ref-type="table" rid="table1">Table 1</xref> in Exercises for People with Hemophilia. &#169; World Federation of Hemophilia 2006. http://elearning.wfh.org/resource/exercises-for-people-with-hemophilia/ [<xref ref-type="bibr" rid="scirp.98297-ref41">41</xref>].</p><p>ROM restrictions in their elbows, etc. The selection of assistive devices must consider multiple joint involvement while simultaneously working toward the ultimate goal of maximizing functional mobility and independence.</p><p>Therefore, we believe that when managing PWH with established musculoskeletal complications, PTs should focus more on improving function and strength within the available and symptom-free ROM and on preventing progressive loss of ROM, rather than on increasing ROM. This strategy is similar to how PTs would treat and manage patients with advanced osteoarthritis (OA) before joint replacement. Additionally, supporting PWH and helping them adapt to their situation and develop appropriate physical compensations may be more beneficial than applying corrective strategies that attempt to achieve normal biomechanics in joints with advanced joint disease.</p></sec><sec id="s4"><title>4. Differences and Similarities between People with Hemophilia and Other Patients Seen by Physical Therapists</title><p>Although some elements are similar, PWH and people with OA have a different underlying pathogenicity, which results in multiple arthrophic joints in hemophilia [<xref ref-type="bibr" rid="scirp.98297-ref46">46</xref>]. This leads to major differences in balance, strength and ROM, compared with patients with OA. In hemophilia, cartilage lesions are diffuse [<xref ref-type="bibr" rid="scirp.98297-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref47">47</xref>], while in the general population requiring physical therapy the lesions are usually more focal, especially in young people with joint damage (see <xref ref-type="table" rid="table2">Table 2</xref>) [<xref ref-type="bibr" rid="scirp.98297-ref48">48</xref>].</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Differences in joint arthropathy in PWH, or individuals with osteoarthritis or rheumatoid arthritis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Hemophilic arthropathy (HA) [<xref ref-type="bibr" rid="scirp.98297-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref54">54</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref55">55</xref>]</th><th align="center" valign="middle" >Osteoarthritis (OA) [<xref ref-type="bibr" rid="scirp.98297-ref56">56</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref57">57</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref58">58</xref>]</th><th align="center" valign="middle" >Rheumatoid arthritis (RA) [<xref ref-type="bibr" rid="scirp.98297-ref59">59</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref60">60</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref61">61</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref62">62</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref63">63</xref>]</th></tr></thead><tr><td align="center" valign="middle" >Shared features with HA</td><td align="center" valign="middle" >-</td><td align="center" valign="middle" > Cartilage degeneration and osteophyte formation</td><td align="center" valign="middle" > Synovitis, cartilage degradation, and bone resorption</td></tr><tr><td align="center" valign="middle" >Presentation</td><td align="center" valign="middle" > Painful acute onset  Joint swelling and damage</td><td align="center" valign="middle" > Gradual joint swelling and enlargement</td><td align="center" valign="middle" > Gradual painful joint swelling and damage</td></tr><tr><td align="center" valign="middle" >Pathophysiology</td><td align="center" valign="middle" > Bleeding directly from synovial lining into the joint</td><td align="center" valign="middle" > Mix of risk factors, including age, sex, injury, wear and tear, obesity, genetics  Biochemical processes involving synovium, cartilage, and bone</td><td align="center" valign="middle" > Genetic basis  Chronic autoimmune disorder  May also include systemic and extra-articular manifestations</td></tr><tr><td align="center" valign="middle" >Major processes</td><td align="center" valign="middle" > Hemarthrosis-induced, widespread synovial inflammation  Acute inflammatory mediators and iron-induced oxygen metabolites cause chondrocyte apoptosis and hemosiderin deposition  Iron increases pro-inflammatory cytokines that increase pannus in synovium  Widespread cartilage destruction and bone changes</td><td align="center" valign="middle" > Synovial inflammation, mostly in regions adjacent to cartilage and bone damage  Activated synovium releases cytokines that accelerate destruction of adjacent cartilage</td><td align="center" valign="middle" > Autoimmune-mediated synovitis causes pannus (through angiogenesis), and leads to bone destruction  Enzymes from synoviocytes and chondrocytes destroy cartilage</td></tr><tr><td align="center" valign="middle" >Age of onset</td><td align="center" valign="middle" > First joint bleed usually occurs in infants (age &lt; 2 years) in most severe cases (varies with severity and quality of prophylaxis)</td><td align="center" valign="middle" > Present in 50% of people &gt; 65 years of age with chronic knee pain</td><td align="center" valign="middle" > Present in 3% - 4% of people 65 - 74 years of age, with prevalence of onset decreasing with age</td></tr><tr><td align="center" valign="middle" >Degree of damage at equivalent age</td><td align="center" valign="middle" > Greater than with OA or RA</td><td align="center" valign="middle" > Less than with HA</td><td align="center" valign="middle" > Less than with HA</td></tr><tr><td align="center" valign="middle" >Severity depends on:</td><td align="center" valign="middle" > Number of hemarthroses  Cumulative biomechanical stresses  Access to medical care, factor infusion concentrate and physical therapy</td><td align="center" valign="middle" > Age  Time since onset  Risk factors (see above)</td><td align="center" valign="middle" > Age at diagnosis  Access to disease-modifying drugs  Smoking status  Disease duration  Joint erosions</td></tr></tbody></table></table-wrap><p>Some information included in this table is based on clinical experience/observations of the authors.</p><p>Although the same structures are commonly affected both in acute injury or arthritis in the general population and in hemophilic bleeding (joint capsule, synovial membrane, proprioceptors, muscles, cartilage, bone), the mechanism of injury is different. Whereas a person without hemophilia may have acute injury and resolution of the insult, in hemophilia a bleeding component is layered on acute injury and causes lingering consequences that are worsened with repeated bleeding. For example, an individual with hemophilia with an ankle sprain will have damage to the ligaments as well as possible bleeding into the muscle or joint. For PWH with an ankle affected by multiple bleeds, balance is affected by episodic joint swellings and the resulting extended periods of immobility. In hemophilia, when the synovium is injured and bleeding occurs, muscle spasms and pain result [<xref ref-type="bibr" rid="scirp.98297-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref45">45</xref>]. Repeated hemarthroses cause distension of the joint capsule, which leads to mechanoreceptor lesions [<xref ref-type="bibr" rid="scirp.98297-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref45">45</xref>]. This contrasts with the situation in the general population, where trauma (such as a sprain) causes tearing, which then results in mechanoreceptor lesions [<xref ref-type="bibr" rid="scirp.98297-ref49">49</xref>]. Therefore, being able to differentiate pain caused by different pathologies is important. Differentiating between an acute joint bleed and arthropathy can be done by assessing the signs and symptoms present. This is a difficult task, and an ultrasound study has shown that even PWH and experienced hemophilia physicians can misdiagnose a painful joint (both failing to identify a bleed, or identifying a bleed incorrectly) [<xref ref-type="bibr" rid="scirp.98297-ref50">50</xref>]. Differentiating factors include: the type of pain; the course of symptoms and their cause; the history of the joint before presentation of current symptoms; and how impaired ROM is during the episode (see <xref ref-type="fig" rid="fig4">Figure 4</xref>) [<xref ref-type="bibr" rid="scirp.98297-ref51">51</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref52">52</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref53">53</xref>].</p><p>ROM tends to decrease with age in both PWH and healthy people, but in the former ROM limitations can begin at an early age and are associated with the number of hemarthroses already experienced [<xref ref-type="bibr" rid="scirp.98297-ref64">64</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref65">65</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref66">66</xref>]. Chronic bleeding into the joint and muscle, inflammation, cartilage damage, and arthropathy lead to limited ROM in PWH, and can be worsened if physical therapy is not conducted [<xref ref-type="bibr" rid="scirp.98297-ref43">43</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref67">67</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref68">68</xref>]. In clinical practice, it is commonly accepted that reduced ROM and muscle shortening can occur in PWH from prolonged protective guarding during hemarthroses (holding the joint in a position of comfort), or from joint limitations due to arthropathy. Loss of ROM may be acute—during an active bleed the joint capsule distends and motion is limited—or chronic, due to complications from previous hemarthroses or hematoma. Progressive loss of ROM significantly correlates with difficulty in walking and increased energy expenditure [<xref ref-type="bibr" rid="scirp.98297-ref44">44</xref>].</p></sec><sec id="s5"><title>5. Adjusting the Physical Therapy Session for an Individual with Hemophilia</title><sec id="s5_1"><title>5.1. Taking a History</title><p>A concise medical history describing the details of problematic symptoms and effectiveness of previous treatments is essential. The person’s goals, motivations, and expectations of physical therapy should be discussed. Owing to the complexity of hemophilia management, musculoskeletal complications and other comorbidities, there are several questions that may help focus an individual’s physical therapy needs, as shown in <xref ref-type="table" rid="table3">Table 3</xref>.</p></sec><sec id="s5_2"><title>5.2. Gaining the Trust of People with Hemophilia</title><p>Most PWH are aware that their condition is rare and that few non-specialist community PTs have experience with it. By acknowledging this, the individual with hemophilia can be viewed as an expert on their condition and a potential resource for useful information. However, to gain the trust of and develop a relationship with an individual with hemophilia, questions that may highlight basic gaps in disease knowledge (e.g. asking how long they have had hemophilia) should be avoided. Individualized management is also important. Because PWH may have multiple joints affected by hemarthropathy, it is critical that the current functional issue is clearly identified and a tailored program is developed to address that area.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Questions to ask PWH in a PT session</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Question to ask the individual</th><th align="center" valign="middle" >Rationale</th></tr></thead><tr><td align="center" valign="middle" > “Why have you come here today?”</td><td align="center" valign="middle" >PWH have many musculoskeletal problems, but may be compensating successfully for some of them. Just asking “What’s wrong?” is therefore not useful, as PWH may be seeking help for a specific muscle, joint, or functional issue.</td></tr><tr><td align="center" valign="middle" > “What is your current hemophilia treatment regimen?”  “Are you on a prophylactic regimen, and if so are you following that plan?”  “When was your last dose?”  “Do you self-infuse?”</td><td align="center" valign="middle" >The PT should be familiar with the person’s hemophilia treatment regimen and the basic principles of clotting factor treatment. Asking about these details will also reassure them that their PT understands hemophilia, and will highlight any problems with adherence to clotting factor treatment.</td></tr><tr><td align="center" valign="middle" > “Who is your contact person at the HTC or hemophilia care provider?”</td><td align="center" valign="middle" >This may help to build a trusted relationship with an individual with hemophilia, and will provide the PT with a source of information on hemophilia. This question also ensures that the treating PT has direct communication with the person’s treatment team, which is critical.</td></tr><tr><td align="center" valign="middle" > “Do you have any other medical issues?”  “Have you undergone surgery recently?”</td><td align="center" valign="middle" >As a result of previous medical treatment for hemophilia, some PWH may be co-infected with HIV or hepatitis C, which has consequences for their treatment (e.g. side effects from HIV medications, increased osteoporosis risk). This may be a sensitive topic for many people, so should be approached with care.</td></tr></tbody></table></table-wrap><p>The questions in this table were identified by the authors based on their experience in managing PWH.</p></sec><sec id="s5_3"><title>5.3. Timing of Session</title><p>A 20 - 30-minute physical therapy session may be too short for PWH, especially if they have limited physical ability. As a result, a longer time slot is often required; for some, disrobing for examination may be difficult and time consuming, and managing the coordination for an exercise or transitioning on and off a treatment table may take longer. Physical therapy sessions should be coordinated and, if possible, scheduled to coincide with a person’s regular factor infusion day (if they receive regular prophylactic infusions) to allow maximal hemostatic coverage and safety during the session. Individuals may need a space to infuse prior to the appointment. The HTC may advise PWH to alter their regular dosage or infuse more frequently while attending physical therapy.</p><p>Hematologists can be contacted if a special prescription to cover longer sessions is required. All individuals are different and should be asked for their preferred appointment time. For example, PWH with multiple arthrophic joints or individuals who have family commitments, and who need to manage multiple medical appointments, may not be able to attend early morning appointments easily.</p></sec><sec id="s5_4"><title>5.4. Practical Advice for Physical Therapy Sessions</title><p>Apart from the points detailed above, there are several practical considerations to managing a PT session with an individual with hemophilia. “Green flags” are helpful best-practice actions that PTs can carry out for the benefit of PWH, and are listed in <xref ref-type="table" rid="table4">Table 4</xref>.</p><p>Likewise, it is essential to recognize “red flags”, which are key indications that something is wrong or key actions that PTs should avoid. To prevent hemarthroses and recognize signs of bleeding, PTs should be aware of these red flags, the most important of which are listed in <xref ref-type="table" rid="table5">Table 5</xref>.</p></sec></sec><sec id="s6"><title>6. Physical Therapy Exercises for People with Hemophilia</title><p>Physical therapy helps to preserve function and slow mobility loss [<xref ref-type="bibr" rid="scirp.98297-ref5">5</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref6">6</xref>]. Some PWH may have small arcs of available ROM, but they can still work on muscle strength. For PWH with fixed postures due to joint disease and muscle involvement, focusing on supportive strategies and prevention of further posture deformity is more important than corrective exercises. In PWH, it is important to observe the entire lower extremity kinetic chain, as multiple joints may be affected.</p><p>Specific exercises may be recommended for physical therapy in PWH [<xref ref-type="bibr" rid="scirp.98297-ref41">41</xref>] :</p><p>• Balance exercises can help prevent falls (the risk of which increases with poor joint status and age) and may be suitable for PWH of all ages [<xref ref-type="bibr" rid="scirp.98297-ref73">73</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref74">74</xref>].</p><p>• Isometric exercises are a safer alternative in PWH with damaged joints where movement and resistance may be harmful [<xref ref-type="bibr" rid="scirp.98297-ref41">41</xref>]. As a basic rule, PWH should progress from isometric to concentric strengthening exercises and from light to moderate resistance.</p><table-wrap id="table4" ><label><xref ref-type="table" rid="table4">Table 4</xref></label><caption><title> Green flags</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Green flag</th><th align="center" valign="middle" >Explanation</th></tr></thead><tr><td align="center" valign="middle" >1) Think long term.</td><td align="center" valign="middle" >As progress can be slow for PWH, thinking in longer timeframes can help (i.e. tracking progress at 2 - 4-week intervals rather than from day to day).</td></tr><tr><td align="center" valign="middle" >2) When assessing musculoskeletal function and joint health, hemophilia-specific tools can be used.</td><td align="center" valign="middle" >Tools such as the HJHS and the Hemophilia Activities List have been developed specifically to measure joint health and functional limitations in PWH, and have been validated [<xref ref-type="bibr" rid="scirp.98297-ref69">69</xref>] . These (and other) hemophilia-specific tools may be helpful to assess and improve outcomes, although PWH tend to prefer short tools [<xref ref-type="bibr" rid="scirp.98297-ref29">29</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref70">70</xref>] . Hemophilia-specific tools should only be used by PTs trained in their use.</td></tr><tr><td align="center" valign="middle" >3) When assessing pain in PWH, consider if there may be joint bleeding.</td><td align="center" valign="middle" >Differential diagnosis is difficult in hemophilia, as there are several pathologies with similar symptoms, and a hemophilic flare-up may also mask pain from a bleed. However, there are several characteristic signs and symptoms that indicate a bleed, including a prodromal sensation of aura, inability to load the joint, tingling sensation, lessening pain after clotting factor treatment, painful palpation of swelling, no locking joint and a feeling of fullness in the joint (see <xref ref-type="fig" rid="fig4">Figure 4</xref>) [<xref ref-type="bibr" rid="scirp.98297-ref51">51</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref52">52</xref>] .</td></tr><tr><td align="center" valign="middle" >4) Include teaching of supportive postures while sitting and focus on joint protection in those with complications from established joint disease.</td><td align="center" valign="middle" >Use of pillows, bolsters, and chairs can encourage a comfortable, ergonomic position and reduce stress on the joints, along with common joint protection techniques, equipment, and devices, as employed in the treatment of OA and rheumatoid arthritis.</td></tr><tr><td align="center" valign="middle" >5) Encourage PWH to make creative use of their adaptive equipment and devices.</td><td align="center" valign="middle" >PWH may use standard equipment and devices (e.g. a mobile walker), with or without modifications, in unconventional ways because they are unable to bear weight through upper extremity joints, owing to blood-induced joint damage. This approach helps PWH live their daily lives in the most effective way for them.</td></tr><tr><td align="center" valign="middle" >6) Work on functional strength (e.g. taking sweater on/off, putting on shoes, sit to stand, steps and stairs) in addition to classic muscle strengthening.</td><td align="center" valign="middle" >These functional strength exercises can be modified as needed (e.g. repetitions of bicep curls at a specific weight), at a level appropriate for the individual with hemophilia [<xref ref-type="bibr" rid="scirp.98297-ref41">41</xref>] .</td></tr><tr><td align="center" valign="middle" >7) Isometric strengthening within a comfortable range may be considered the safest type of strengthening.</td><td align="center" valign="middle" >Isometrics focus solely on the muscle, without placing undue stress on joint structures, which may be damaged in PWH. Owing to the static nature of isometrics, it is commonly believed that there is little risk of impinging on hypertrophied synovial tissue, as could be the case during isotonic exercise. There should be a focus on a gradual progression from isometric to isotonic, within a pain-free ROM, and finally progressive, resistive exercises. Closed-chain versus open-chain formats should be considered to minimize risk.</td></tr><tr><td align="center" valign="middle" >8) Day-to-day functional postures can be assessed in the clinical examination room.</td><td align="center" valign="middle" >This can be measured by examining how PWH conduct activities such as rising from a chair and standing at the sink to wash. Hints, tips, and prompts can be taught to enhance stability and control in such positions.</td></tr><tr><td align="center" valign="middle" >9) Ensure PWH have sufficient hemostatic cover before commencing each physical therapy session, as recommended by their HTC.</td><td align="center" valign="middle" >This treatment may or may not be necessary depending on the severity of hemophilia and the factor infusion regimen prescribed by the HTC. This may involve clotting factor treatment before each physical therapy session (for example in post-surgery cases), which most PWH will typically administer themselves.</td></tr><tr><td align="center" valign="middle" >10) It is essential to highlight the importance of adhering to the prescribed factor replacement regimen and the consequences of non-adherence (e.g. the consequences of bleeding).</td><td align="center" valign="middle" >This is particularly useful for groups in which adherence is often problematic, for example in adolescents or in older adults with poor venous access from years of infusing.</td></tr></tbody></table></table-wrap><table-wrap id="table5" ><label><xref ref-type="table" rid="table5">Table 5</xref></label><caption><title> Red flags</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Red flag</th><th align="center" valign="middle" >Explanation</th></tr></thead><tr><td align="center" valign="middle" >1) A combination of severe pain in the groin, motor and sensory loss in femoral nerve distribution, and flexed hip and knee (the “psoas sign”) could indicate an iliopsoas injury or bleed [<xref ref-type="bibr" rid="scirp.98297-ref18">18</xref>] .</td><td align="center" valign="middle" >When distinguishing between hip hemarthroses and iliopsoas bleeds, the former cause pain with passive and active motion in any direction, and limited ROM; the latter present with pain in the groin on active hip flexion or active and passive hip extension, but less painful passive flexion [<xref ref-type="bibr" rid="scirp.98297-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref71">71</xref>] . An individual with hemophilia with a hemarthrosis or muscle bleed should be referred back to their HTC. However, the psoas sign should be treated as a medical emergency, as psoas bleeds may be life-threatening if not urgently treated with clotting factor replacement [<xref ref-type="bibr" rid="scirp.98297-ref18">18</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref71">71</xref>] .</td></tr><tr><td align="center" valign="middle" >2) Proprioceptive exercises may lead to bleeding if conducted too early after a hemarthrosis or in the presence of chronic synovitis. Appropriate care should be taken.</td><td align="center" valign="middle" >These exercises are advanced, typically involving minor corrective movements and rotation in combination with weight bearing. They have a tendency to mechanically pinch a swollen, hypertrophied, highly vascular synovium, which can precipitate a hemarthrosis.</td></tr><tr><td align="center" valign="middle" >3) Traditional posture exercises with end-range positions (such as aggressive stretching of fibrosed joints) should be avoided, as these exercises could aggravate arthropathy or generate new bleeds in joints or soft tissue.</td><td align="center" valign="middle" >Hard end-feels and bony blocks can indicate arthropathy; in the presence of these signs, aggressive traditional exercises should be avoided. PWH may want to train on their own at home or at a fitness center without seeking guidance on appropriate muscle strength exercises from PTs. In these circumstances, it should be emphasized that end-range position exercises may cause hemarthroses and be detrimental to their joint health. The focus of physical therapy exercises should instead be on supportive strategies and within the available ROM in those with severe joint disease.</td></tr><tr><td align="center" valign="middle" >4) PTs must stretch chronic joint flexion contractures with caution.</td><td align="center" valign="middle" >Stretching of any contracture (see <xref ref-type="fig" rid="fig5">Figure 5</xref>) in PWH should be undertaken with a high degree of caution and extremely slowly; acute contractures should be referred immediately to the HTC. This is very different from the approach used in the general population, where stretching is encouraged. Aggressive joint mobilization and high-velocity manipulations can cause a hemarthrosis and may be contraindicated.</td></tr><tr><td align="center" valign="middle" >5) New or acute pain may indicate a new hemarthrosis or bleed.</td><td align="center" valign="middle" >Sometimes PWH struggle to distinguish bleed pain from arthropathy flares from soreness experienced at the beginning of a new exercise regimen. PTs can assess the joint to determine the cause of pain before proceeding with treatment or exercise recommendations.</td></tr><tr><td align="center" valign="middle" >6) PWH with inhibitors have a more complex form of hemophilia and their bleeding is more difficult to control; they should be managed only by PTs specialized in hemophilia at the HTC (where available).</td><td align="center" valign="middle" >Inhibitors are a serious complication of hemophilia, where PWH develop antibodies against the clotting factor, and bleeding and joint disease can be more severe than usual [<xref ref-type="bibr" rid="scirp.98297-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref24">24</xref>] . In these people, infusions of factor concentrates typically do not control bleeding, which may instead be managed with bypassing agents or an antibody therapeutic [<xref ref-type="bibr" rid="scirp.98297-ref7">7</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref24">24</xref>] . Individuals with inhibitors often have more lengthy and poorly controlled coagulation, and more joint damage at younger ages vs those without inhibitors [<xref ref-type="bibr" rid="scirp.98297-ref23">23</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref24">24</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref72">72</xref>] . PTs treating these patients should proceed with great care, with delicate physical assessment and a slow progression of interventions. Ideally, PWH with inhibitors should be treated by experienced PTs in an HTC, where they may receive immediate assessment and intervention from a hematologist or nurse if needed.</td></tr></tbody></table></table-wrap><p>• Low-load static stretching/bracing or dynamic bracing, with a very gradual wearing/progression schedule. In general, active ROM should be preferred to passive ROM, as it is safer.</p><p>• Gentle myofascial release and other gentle manual techniques may be indicated for PWH [<xref ref-type="bibr" rid="scirp.98297-ref75">75</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref76">76</xref>], in opposition to high-velocity manipulation and joint mobilization techniques.</p><p>Other exercises recommended for PWH can be found in a guide published by the World Federation of Hemophilia (WFH), or on the TalkingJoints&#174; website [<xref ref-type="bibr" rid="scirp.98297-ref22">22</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref41">41</xref>].</p><p>Starting exercise very gradually is advised, as many PWH may be sedentary or not participating in regular exercise. PTs should cautiously add to the regimen in the following weeks, progressively applying more advanced proprioceptive exercises, and taking into account the prolonged healing rate in PWH. PTs must remember that, as for anyone, prescribing too many exercises may cause adherence issues. This is especially true for PWH who could be managing multiple complications and may not be accustomed to physical activity. At all times, awareness of early signs of bleeding or synovitis, which may be precipitated by physical therapy or exercise, is essential, as is withholding exercise to an affected joint during a bleed.</p><p>For PWH who exhibit a risk of falling, as gait and functional mobility decline, the use of assistive devices and treatment techniques that focus on dynamic balance should be considered. PTs can suggest supportive or protective devices, such as orthoses, to improve function and reduce pain with minimal side effects [<xref ref-type="bibr" rid="scirp.98297-ref77">77</xref>]. Power mobility may be considered for PWH functioning at a community level of independence, to preserve and protect affected joints and reduce bleeding. In the authors’ experience, a manual wheelchair may be more challenging, and individuals with affected upper extremity joints and frequent hemarthroses may be unable to propel them.</p><p>Even if the individual with hemophilia has advanced joint disease or poor joint health or function, the PT can still work towards and encourage a state of wellness with supervised exercise programs [<xref ref-type="bibr" rid="scirp.98297-ref39">39</xref>]. These should be part of the overall treatment and may help decrease hemarthroses and arthritic joint pain [<xref ref-type="bibr" rid="scirp.98297-ref7">7</xref>]. With guidance, communication and collaboration between the HTC, personal trainer and PT, PWH may be capable of undertaking an effective exercise program at a fitness facility.</p></sec><sec id="s7"><title>7. Communication with the Hemophilia Treatment Center and When to Refer to Hemophilia Specialists</title><p>Communication between local PTs and the HTC is recommended throughout treatment as needed, starting from when the individual is referred. Effective communication with the HTC team and the specialist PT helps the local PT gain a wider knowledge of hemophilia. It can also help gain essential information, such as the needs and infusion schedules of PWH and any relevant regulations regarding prescriptions and reimbursement. The HTC can also answer any questions the PT may have, such as what to do if bleeding is suspected. It is important that the PT has a good understanding of the person’s bleeding history and treatment regimen. PTs can also find helpful information on hemophilia from the WFH, National Hemophilia Foundation (NHF), and the European Association for Haemophilia and Allied Disorders (EAHAD), among others [<xref ref-type="bibr" rid="scirp.98297-ref78">78</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref79">79</xref>] [<xref ref-type="bibr" rid="scirp.98297-ref80">80</xref>].</p><p>PTs should consider a referral back to the HTC if an individual with hemophilia:</p><p>• Thinks they have unusual or unfamiliar symptoms, uncontrolled bleeding, reduced response to factor treatment, or uncontrolled pain;</p><p>• Requires psychosocial support, displays mental health symptoms, or has problems with motivation/attending appointments.</p></sec><sec id="s8"><title>8. Conclusion</title><p>PWH require individualized management while undergoing physical therapy. To improve their knowledge of the condition, PTs should acknowledge the expertise of PWH and communicate effectively with them and with their HTC to optimize care. In this article, the joint pathology in hemophilia and its consequences have been detailed, and practical advice on how to conduct physical therapy assessments and exercises have been presented. Therefore, this article is a useful practical resource for local PTs who are inexperienced in hemophilia. In conjunction with self-directed learning in haemophilia and in close communication with experienced HTCs, this article may help these PTs to learn more about the condition and the nuances of conducting physical therapy in PWH. With proper guidance and collaboration with the individual with hemophilia, HTC and experienced hemophilia PT, local PTs can treat PWH effectively and safely.</p></sec><sec id="s9"><title>Acknowledgements</title><p>All authors contributed to the content of the manuscript, reviewed it critically at each stage of development and approved the final version for submission. We thank Flavia Sciota, Ph.D., AXON Communications, who received compensation from Novo Nordisk for medical writing and editorial assistance. Novo Nordisk was also provided with the opportunity to perform a medical accuracy review. This manuscript was developed in compliance with Good Publication Practice Guidelines.</p></sec><sec id="s10"><title>Conflicts of Interest</title><p>A.F. has received consultancy honoraria from Aptevo, Blood CME Center, National Hemophilia Foundation, Novo Nordisk, and Shire, and reports no conflict of interest regarding this publication. G.B. has received honoraria from Novo Nordisk and Shire, funding to attend congresses from Pfizer, consultancy fees from Novo Nordisk, and personal fees from Shire. S.L. has received honoraria from Bayer, CSL-Behring, Novo Nordisk, Pfizer, Roche, Sobi, and Takeda. P.McL. has received honoraria from Novo Nordisk, Sobi and Takeda.</p></sec><sec id="s11"><title>Cite this paper</title><p>Forsyth, A., Blamey, G., Lobet, S. and McLaughlin, P. (2020) Practical Guidance for Non-Specialist Physical Therapists Managing People with Hemophilia and Musculoskeletal Complications. Health, 12, 158-179. https://doi.org/10.4236/health.2020.122014</p></sec></body><back><ref-list><title>References</title><ref id="scirp.98297-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Pulles, A.E., Mastbergen, S.C., Schutgens, R.E., Lafeber, F.P. and van Vulpen, L.F. (2017) Pathophysiology of Hemophilic Arthropathy and Potential Targets for Therapy. Pharmacological Research, 115, 192-199.  
https://doi.org/10.1016/j.phrs.2016.11.032</mixed-citation></ref><ref id="scirp.98297-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Mulder, K. and Llinás, A. (2004) The Target Joint. Haemophilia, 10(Suppl 4), 152-156. https://doi.org/10.1111/j.1365-2516.2004.00976.x</mixed-citation></ref><ref id="scirp.98297-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Rodriguez-Merchan, E.C. (2016) Articular Bleeding in Hemophilia. Cardiovascular &amp; Hematological Disorders-Drug Targets, 16, 21-24.  
https://doi.org/10.2174/1871529X16666160613114506</mixed-citation></ref><ref id="scirp.98297-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Blamey, G., Forsyth, A., Zourikian, N., Short, L., Jankovic, N., et al. (2010) Comprehensive Elements of a Physiotherapy Exercise Programme in Haemophilia—A Global Perspective. Haemophilia, 16(Suppl 5), 136-145.  
https://doi.org/10.1111/j.1365-2516.2010.02312.x</mixed-citation></ref><ref id="scirp.98297-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Hanley, J., McKernan, A., Creagh, M.D., Classey, S., McLaughlin, P., et al. (2017) Guidelines for the Management of Acute Joint Bleeds and Chronic Synovitis in Haemophilia: A United Kingdom Haemophilia Centre Doctors’ Organisation (UKHCDO) Guideline. Haemophilia, 23, 511-520.  
https://doi.org/10.1111/hae.13201</mixed-citation></ref><ref id="scirp.98297-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Atilla, B. and Güney-Deniz, H. (2019) Musculoskeletal Treatment in Haemophilia. EFORT Open Reviews, 4, 230-239. https://doi.org/10.1302/2058-5241.4.180068</mixed-citation></ref><ref id="scirp.98297-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Srivastava, A., Brewer, A.K., Mauser-Bunschoten, E.P., Key, N.S., Kitchen, S., et al. (2013) Guidelines for the Management of Hemophilia. Haemophilia, 19, e1-e47.  
https://doi.org/10.1111/j.1365-2516.2012.02909.x</mixed-citation></ref><ref id="scirp.98297-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Scott, M.J., Xiang, H., Hart, D.P., Palmer, B., Collins, P.W., et al. (2019) Treatment Regimens and Outcomes in Severe and Moderate Haemophilia A in the UK: The THUNDER Study. Haemophilia, 25, 205-212. https://doi.org/10.1111/hae.13616</mixed-citation></ref><ref id="scirp.98297-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Baker, J.R., Crudder, S.O., Riske, B., Bias, V. and Forsberg, A. (2005) A Model for a Regional System of Care to Promote the Health and Well-Being of People with Rare Chronic Genetic Disorders. American Journal of Public Health, 95, 1910-1916.  
https://doi.org/10.2105/AJPH.2004.051318</mixed-citation></ref><ref id="scirp.98297-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Stephensen, D., de Kleijn, P., Matlary, R.E.D., Katzerova, M., McLaughlin, P., et al. (2019) Scope of Practice of Haemophilia Physiotherapists: A European Survey. Haemophilia, 25, 514-520. https://doi.org/10.1111/hae.13727</mixed-citation></ref><ref id="scirp.98297-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Jansen, N.W.D., Roosendaal, G. and Lafeber, F.P.J.G. (2008) Understanding Haemophilic Arthropathy: An Exploration of Current Open Issues. British Journal of Haematology, 143, 632-640. https://doi.org/10.1111/j.1365-2141.2008.07386.x</mixed-citation></ref><ref id="scirp.98297-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Rodriguez-Merchan, E.C. (2008) Articular Bleeding (Hemarthrosis) in Hemophilia. World Federation of Hemophilia.  
https://elearning.wfh.org/resource/articular-bleeding-hemarthrosis-in-hemophilia-an-orthopedists-point-of-view/</mixed-citation></ref><ref id="scirp.98297-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Kuijlaars, I.A.R., Timmer, M.A., de Kleijn, P., Pisters, M.F. and Fischer, K. (2017) Monitoring Joint Health in Haemophilia: Factors Associated with Deterioration. Haemophilia, 23, 934-940. https://doi.org/10.1111/hae.13327</mixed-citation></ref><ref id="scirp.98297-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Lobet, S., Hermans, C. and Lambert, C. (2014) Optimal Management of Hemophilic Arthropathy and Hematomas. Journal of Blood Medicine, 5, 207-218.  
https://doi.org/10.2147/JBM.S50644</mixed-citation></ref><ref id="scirp.98297-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Manco-Johnson, M.J., Abshire, T.C., Shapiro, A.D., Riske, B., Hacker, M.R., et al. (2007) Prophylaxis versus Episodic Treatment to Prevent Joint Disease in Boys with Severe Hemophilia. New England Journal of Medicine, 357, 535-544.  
https://doi.org/10.1056/NEJMoa067659</mixed-citation></ref><ref id="scirp.98297-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Goto, M., Takedani, H., Nitta, O. and Kawama, K. (2015) Joint Function and Arthropathy Severity in Patients with Hemophilia. Journal of the Japanese Physical Therapy Association, 18, 15-22. https://doi.org/10.1298/jjpta.Vol18_003</mixed-citation></ref><ref id="scirp.98297-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Philipp, C. (2010) The Aging Patient with Hemophilia: Complications, Comorbidities, and Management Issues. Hematology/American Society of Hematology Education Program, 2010, 191-196. https://doi.org/10.1182/asheducation-2010.1.191</mixed-citation></ref><ref id="scirp.98297-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Buzzard, B. and Jones, P. (1988) Physiotherapy Management of Haemophilia: An Update. Physiotherapy, 74, 221-226.  
https://doi.org/10.1016/S0031-9406(10)63535-3</mixed-citation></ref><ref id="scirp.98297-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Escobar, M.A., Brewer, A., Caviglia, H., Forsyth, A., Jimenez-Yuste, V., et al. (2018) Recommendations on Multidisciplinary Management of Elective Surgery in People with Haemophilia. Haemophilia, 24, 693-702. https://doi.org/10.1111/hae.13549</mixed-citation></ref><ref id="scirp.98297-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">De la Corte-Rodriguez, H. and Rodriguez-Merchan, E.C. (2013) The Role of Physical Medicine and Rehabilitation in Haemophiliac Patients. Blood Coagulation &amp; Fibrinolysis, 24, 1-9. https://doi.org/10.1097/MBC.0b013e32835a72f3</mixed-citation></ref><ref id="scirp.98297-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Guodemar-Pérez, J., Ruiz-López, M., Rodríguez-López, E., García-Fernández, P. and Hervás-Pérez, J.P. (2017) Physiotherapy Treatments in Musculoskeletal Pathologies Associated with Haemophilia. A Literature Review. Hamostaseologie, 38, 141-149.</mixed-citation></ref><ref id="scirp.98297-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Novo Nordisk (2016) TalkingJoints&amp;reg;. 
http://www.novonordisk.com/about-novo-nordisk/changing-haemophilia/changing-haemophilia-focus-areas/joint-outcomes/talking-joints.html</mixed-citation></ref><ref id="scirp.98297-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Morfini, M., Haya, S., Tagariello, G., Pollmann, H., Quintana, M., et al. (2007) European Study on Orthopaedic Status of Haemophilia Patients with Inhibitors. Haemophilia, 13, 606-612. https://doi.org/10.1111/j.1365-2516.2007.01518.x</mixed-citation></ref><ref id="scirp.98297-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Ljung, R., Auerswald, G., Benson, G., Dolan, G., Duffy, A., et al. (2019) Inhibitors in Haemophilia A and B: Management of Bleeds, Inhibitor Eradication and Strategies for Difficult-to-Treat Patients. European Journal of Haematology, 102, 111-122.  
https://doi.org/10.1111/ejh.13193</mixed-citation></ref><ref id="scirp.98297-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Bolton-Maggs, P.H. and Pasi, K.J. (2003) Haemophilias A and B. The Lancet, 361, 1801-1809. https://doi.org/10.1016/S0140-6736(03)13405-8</mixed-citation></ref><ref id="scirp.98297-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Riley, R.R., Witkop, M., Hellman, E. and Akins, S. (2011) Assessment and Management of Pain in Haemophilia Patients. Haemophilia, 17, 839-845.  
https://doi.org/10.1111/j.1365-2516.2011.02567.x</mixed-citation></ref><ref id="scirp.98297-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Tagliaferri, A., Franchini, M., Rivolta, G.F., Farace, S., Quintavalle, G., et al. (2018) Pain Assessment and Management in Haemophilia: A Survey among Italian Patients and Specialist Physicians. Haemophilia, 24, 766-773.  
https://doi.org/10.1111/hae.13600</mixed-citation></ref><ref id="scirp.98297-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Humphries, T.J. and Kessler, C.M. (2015) Managing Chronic Pain in Adults with Haemophilia: Current Status and Call to Action. Haemophilia, 21, 41-51.  
https://doi.org/10.1111/hae.12526</mixed-citation></ref><ref id="scirp.98297-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Bradshaw, E., McClellan, C., Whybrow, P. and Cramp, F. (2019) Physiotherapy Outcome Measures of Haemophilia Acute Bleed Episodes: What Matters to Patients? Haemophilia, 25, 1066-1072. https://doi.org/10.1111/hae.13840</mixed-citation></ref><ref id="scirp.98297-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Hawker, G.A., Mian, S., Kendzerska, T. and French, M. (2011) Measures of Adult Pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care &amp; Research, 63(Suppl 11), S240-S252.  
https://doi.org/10.1002/acr.20543</mixed-citation></ref><ref id="scirp.98297-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Herdman, M., Gudex, C., Lloyd, A., Janssen, M., Kind, P., et al. (2011) Development and Preliminary Testing of the New Five-Level Version of EQ-5D (EQ-5D-5L). Quality of Life Research, 20, 1727-1736. https://doi.org/10.1007/s11136-011-9903-x</mixed-citation></ref><ref id="scirp.98297-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Torres-Ortuno, A., Cuesta-Barriuso, R., Nieto-Munuera, J., Galindo-Pinana, P. and López-Pina, J.A. (2019) Coping Strategies in Young and Adult Haemophilia Patients: A Tool for the Adaptation to the Disease. Haemophilia, 25, 392-397.  
https://doi.org/10.1111/hae.13743</mixed-citation></ref><ref id="scirp.98297-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Wang, C.Z., Moss, J. and Yuan, C.S. (2015) Commonly Used Dietary Supplements on Coagulation Function during Surgery. Medicines (Basel), 2, 157-185.  
https://doi.org/10.3390/medicines2030157</mixed-citation></ref><ref id="scirp.98297-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Franchini, M., Tagliaferri, A. and Mannucci, P.M. (2007) The Management of Hemophilia in Elderly Patients. Clinical Interventions in Aging, 2, 361-368.</mixed-citation></ref><ref id="scirp.98297-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Lobet, S., Pendeville, E., Dalzell, R., Defalque, A., Lambert, C., et al. (2008) The Role of Physiotherapy after Total Knee Arthroplasty in Patients with Haemophilia. Haemophilia, 14, 989-998. https://doi.org/10.1111/j.1365-2516.2008.01748.x</mixed-citation></ref><ref id="scirp.98297-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Souza, F.M., McLaughlin, P., Pereira, R.P., Minuque, N.P., Mello, M.H., et al. (2013) The Effects of Repetitive Haemarthrosis on Postural Balance in Children with Haemophilia. Haemophilia, 19, e212-e217. https://doi.org/10.1111/hae.12106</mixed-citation></ref><ref id="scirp.98297-ref37"><label>37</label><mixed-citation publication-type="other" xlink:type="simple">Ragni, M.V. (2011) Aging in Haemophilia: Getting to the Heart of the Matter. Thrombosis and Haemostasis, 105, 207-208. https://doi.org/10.1160/TH10-12-0818</mixed-citation></ref><ref id="scirp.98297-ref38"><label>38</label><mixed-citation publication-type="other" xlink:type="simple">Fearn, M., Hill, K., Williams, S., Mudge, L., Walsh, C., et al. (2010) Balance Dysfunction in Adults with Haemophilia. Haemophilia, 16, 606-614.  
https://doi.org/10.1111/j.1365-2516.2010.02200.x</mixed-citation></ref><ref id="scirp.98297-ref39"><label>39</label><mixed-citation publication-type="other" xlink:type="simple">Mulvany, R., Zucker-Levin, A.R., Jeng, M., Joyce, C., Tuller, J., et al. (2010) Effects of a 6-Week, Individualized, Supervised Exercise Program for People with Bleeding Disorders and Hemophilic Arthritis. Physical Therapy, 90, 509-526.  
https://doi.org/10.2522/ptj.20080202</mixed-citation></ref><ref id="scirp.98297-ref40"><label>40</label><mixed-citation publication-type="other" xlink:type="simple">Brown, D., Claffey, A. and Harding, R. (2016) Evaluation of a Physiotherapy-Led Group Rehabilitation Intervention for Adults Living with HIV: Referrals, Adherence and Outcomes. AIDS Care, 28, 1495-1505.  
https://doi.org/10.1080/09540121.2016.1191611</mixed-citation></ref><ref id="scirp.98297-ref41"><label>41</label><mixed-citation publication-type="other" xlink:type="simple">Mulder, K. (2006) Exercises for People with Hemophilia. World Federation of Hemophilia.  
http://elearning.wfh.org/resource/exercises-for-people-with-hemophilia/</mixed-citation></ref><ref id="scirp.98297-ref42"><label>42</label><mixed-citation publication-type="other" xlink:type="simple">Lobet, S., Detrembleur, C., Francq, B. and Hermans, C. (2010) Natural Progression of Blood-Induced Joint Damage in Patients with Haemophilia: Clinical Relevance and Reproducibility of Three-Dimensional Gait Analysis. Haemophilia, 16, 813-821.  
https://doi.org/10.1111/j.1365-2516.2010.02245.x</mixed-citation></ref><ref id="scirp.98297-ref43"><label>43</label><mixed-citation publication-type="other" xlink:type="simple">Lobet, S., Detrembleur, C. and Hermans, C. (2013) Impact of Multiple Joint Impairments on the Energetics and Mechanics of Walking in Patients with Haemophilia. Haemophilia, 19, e66-e72. https://doi.org/10.1111/hae.12001</mixed-citation></ref><ref id="scirp.98297-ref44"><label>44</label><mixed-citation publication-type="other" xlink:type="simple">Lobet, S., Detrembleur, C., Massaad, F. and Hermans, C. (2013) Three-Dimensional Gait Analysis Can Shed New Light on Walking in Patients with Haemophilia. The Scientific World Journal, 2013, Article ID: 284358.  
https://doi.org/10.1155/2013/284358</mixed-citation></ref><ref id="scirp.98297-ref45"><label>45</label><mixed-citation publication-type="other" xlink:type="simple">Lobet, S., McCarthy, A., Hermans, C., Peerlinck, K., Matricali, G.A., et al. (2017) Biomechanical Markers and Theoretical Concepts Related to Haemophilic Ankle and Subtalar Joint Arthropathy: Introducing the Term “Haemophilic Tarsal Pan-Arthropathy”. Haemophilia, 23, e250-e258. https://doi.org/10.1111/hae.13202</mixed-citation></ref><ref id="scirp.98297-ref46"><label>46</label><mixed-citation publication-type="other" xlink:type="simple">Wyseure, T., Mosnier, L.O. and von Drygalski, A. (2016) Advances and Challenges in Hemophilic Arthropathy. Seminars in Hematology, 53, 10-19.  
https://doi.org/10.1053/j.seminhematol.2015.10.005</mixed-citation></ref><ref id="scirp.98297-ref47"><label>47</label><mixed-citation publication-type="book" xlink:type="simple">Vanhoenacker, F., Van Dyck, P., Gielen, J. and De Schepper, A. (2014) Tumor and Tumor-Like Lesions of Soft Tissue. In: Davies, A., Grainger, A. and James, S., Eds., Imaging of the Hand and Wrist: Techniques and Applications, Springer Science &amp; Business Media, Berlin, Heidelberg, 317-348. https://doi.org/10.1007/174_2010_113</mixed-citation></ref><ref id="scirp.98297-ref48"><label>48</label><mixed-citation publication-type="other" xlink:type="simple">Falah, M., Nierenberg, G., Soudry, M., Hayden, M. and Volpin, G. (2010) Treatment of Articular Cartilage Lesions of the Knee. International Orthopaedics, 34, 621-630.  
https://doi.org/10.1007/s00264-010-0959-y</mixed-citation></ref><ref id="scirp.98297-ref49"><label>49</label><mixed-citation publication-type="other" xlink:type="simple">Hung, Y.J. (2015) Neuromuscular Control and Rehabilitation of the Unstable Ankle. World Journal of Orthopedics, 6, 434-438.  
https://doi.org/10.5312/wjo.v6.i5.434</mixed-citation></ref><ref id="scirp.98297-ref50"><label>50</label><mixed-citation publication-type="other" xlink:type="simple">Ceponis, A., Wong-Sefidan, I., Glass, C.S. and von Drygalski, A. (2013) Rapid Musculoskeletal Ultrasound for Painful Episodes in Adult Haemophilia Patients. Haemophilia, 19, 790-798. https://doi.org/10.1111/hae.12175</mixed-citation></ref><ref id="scirp.98297-ref51"><label>51</label><mixed-citation publication-type="other" xlink:type="simple">Timmer, M.A., Pisters, M.F., de Kleijn, P., Veenhof, C., Laros-van Gorkom, B.A., et al. (2016) How Do Patients and Professionals Differentiate between Intra-Articular Joint Bleeds and Acute Flare-Ups of Arthropathy in Patients with Haemophilia? Haemophilia, 22, 368-373. https://doi.org/10.1111/hae.12858</mixed-citation></ref><ref id="scirp.98297-ref52"><label>52</label><mixed-citation publication-type="other" xlink:type="simple">Timmer, M.A., Pisters, M.F., de Kleijn, P., de Bie, R.A., Fischer, K., et al. (2015) Differentiating between Signs of Intra-Articular Joint Bleeding and Chronic Arthropathy in Haemophilia: A Narrative Review of the Literature. Haemophilia, 21, 289-296. https://doi.org/10.1111/hae.12667</mixed-citation></ref><ref id="scirp.98297-ref53"><label>53</label><mixed-citation publication-type="other" xlink:type="simple">Stephensen, D., Bladen, M. and McLaughlin, P. (2018) Recent Advances in Musculoskeletal Physiotherapy for Haemophilia. Therapeutic Advances in Hematology, 9, 227-237. https://doi.org/10.1177/2040620718784834</mixed-citation></ref><ref id="scirp.98297-ref54"><label>54</label><mixed-citation publication-type="other" xlink:type="simple">Melchiorre, D., Manetti, M. and Matucci-Cerinic, M. (2017) Pathophysiology of Hemophilic Arthropathy. Journal of Clinical Medicine, 6, E63.  
https://doi.org/10.3390/jcm6070063</mixed-citation></ref><ref id="scirp.98297-ref55"><label>55</label><mixed-citation publication-type="other" xlink:type="simple">Kulkarni, R. and Lusher, J. (2001) Perinatal Management of Newborns with Haemophilia. British Journal of Haematology, 112, 264-274.  
https://doi.org/10.1046/j.1365-2141.2001.02362.x</mixed-citation></ref><ref id="scirp.98297-ref56"><label>56</label><mixed-citation publication-type="other" xlink:type="simple">Krasnokutsky, S., Attur, M., Palmer, G., Samuels, J. and Abramson, S.B. (2008) Current Concepts in the Pathogenesis of Osteoarthritis. Osteoarthritis and Cartilage, 16(Suppl 3), S1-S3. https://doi.org/10.1016/j.joca.2008.06.025</mixed-citation></ref><ref id="scirp.98297-ref57"><label>57</label><mixed-citation publication-type="other" xlink:type="simple">Blagojevic, M., Jinks, C., Jeffery, A. and Jordan, K.P. (2010) Risk Factors for Onset of Osteoarthritis of the Knee in Older Adults: A Systematic Review and Meta-Analysis. Osteoarthritis and Cartilage, 18, 24-33. https://doi.org/10.1016/j.joca.2009.08.010</mixed-citation></ref><ref id="scirp.98297-ref58"><label>58</label><mixed-citation publication-type="other" xlink:type="simple">Shane Anderson, A. and Loeser, R.F. (2010) Why Is Osteoarthritis an Age-Related Disease? Best Practice &amp; Research Clinical Rheumatology, 24, 15-26.  
https://doi.org/10.1016/j.berh.2009.08.006</mixed-citation></ref><ref id="scirp.98297-ref59"><label>59</label><mixed-citation publication-type="other" xlink:type="simple">Pease, C.T., Bhakta, B.B., Devlin, J. and Emery, P. (1999) Does the Age of Onset of Rheumatoid Arthritis Influence Phenotype?: A Prospective Study of Outcome and Prognostic Factors. Rheumatology (Oxford), 38, 228-234.  
https://doi.org/10.1093/rheumatology/38.3.228</mixed-citation></ref><ref id="scirp.98297-ref60"><label>60</label><mixed-citation publication-type="other" xlink:type="simple">Choy, E. (2012) Understanding the Dynamics: Pathways Involved in the Pathogenesis of Rheumatoid Arthritis. Rheumatology (Oxford), 51(Suppl 5), v3-v11.  
https://doi.org/10.1093/rheumatology/kes113</mixed-citation></ref><ref id="scirp.98297-ref61"><label>61</label><mixed-citation publication-type="other" xlink:type="simple">Smolen, J.S., Aletaha, D. and McInnes, I.B. (2016) Rheumatoid Arthritis. The Lancet, 388, 2023-2038. https://doi.org/10.1016/S0140-6736(16)30173-8</mixed-citation></ref><ref id="scirp.98297-ref62"><label>62</label><mixed-citation publication-type="other" xlink:type="simple">Saag, K.G., Cerhan, J.R., Kolluri, S., Ohashi, K., Hunninghake, G.W., et al. (1997) Cigarette Smoking and Rheumatoid Arthritis Severity. Annals of the Rheumatic Diseases, 56, 463-469. https://doi.org/10.1136/ard.56.8.463</mixed-citation></ref><ref id="scirp.98297-ref63"><label>63</label><mixed-citation publication-type="other" xlink:type="simple">Solomon, D.H., Kremer, J., Curtis, J.R., Hochberg, M.C., Reed, G., et al. (2010) Explaining the Cardiovascular Risk Associated with Rheumatoid Arthritis: Traditional Risk Factors versus Markers of Rheumatoid Arthritis Severity. Annals of the Rheumatic Diseases, 69, 1920-1925. https://doi.org/10.1136/ard.2009.122226</mixed-citation></ref><ref id="scirp.98297-ref64"><label>64</label><mixed-citation publication-type="other" xlink:type="simple">Centers for Disease Control and Prevention (2010) Normal Joint Range of Motion Study. https://www.cdc.gov/ncbddd/jointrom/</mixed-citation></ref><ref id="scirp.98297-ref65"><label>65</label><mixed-citation publication-type="other" xlink:type="simple">Soucie, J.M., Cianfrini, C., Janco, R.L., Kulkarni, R., Hambleton, J., et al. (2004) Joint Range-of-Motion Limitations among Young Males with Hemophilia: Prevalence and Risk Factors. Blood, 103, 2467-2473.</mixed-citation></ref><ref id="scirp.98297-ref66"><label>66</label><mixed-citation publication-type="other" xlink:type="simple">Soucie, J.M., Wang, C., Forsyth, A., Funk, S., Denny, M., et al. (2011) Range of Motion Measurements: Reference Values and a Database for Comparison Studies. Haemophilia, 17, 500-507. https://doi.org/10.1111/j.1365-2516.2010.02399.x</mixed-citation></ref><ref id="scirp.98297-ref67"><label>67</label><mixed-citation publication-type="other" xlink:type="simple">Gilbert, M.S. (2000) Musculoskeletal Complications of Haemophilia: The Joint. Haemophilia, 6(Suppl 1), 34-37. https://doi.org/10.1046/j.1365-2516.2000.00044.x</mixed-citation></ref><ref id="scirp.98297-ref68"><label>68</label><mixed-citation publication-type="other" xlink:type="simple">Blanchette, V.S., Key, N.S., Ljung, L.R., Manco-Johnson, M.J., van den Berg, H.M., et al. (2014) Definitions in Hemophilia: Communication from the SSC of the ISTH. Journal of Thrombosis and Haemostasis, 12, 1935-1939.  
https://doi.org/10.1111/jth.12672</mixed-citation></ref><ref id="scirp.98297-ref69"><label>69</label><mixed-citation publication-type="other" xlink:type="simple">McLaughlin, P., Morris, R. and Chowdary, P. (2018) Investigating the Relationship between the HJHS and HAL in Routine Clinical Practice: A Retrospective Review. Haemophilia, 24, 988-994. https://doi.org/10.1111/hae.13614</mixed-citation></ref><ref id="scirp.98297-ref70"><label>70</label><mixed-citation publication-type="other" xlink:type="simple">Seuser, A., Djambas Khayat, C., Negrier, C., Sabbour, A. and Heijnen, L. (2018) Evaluation of Early Musculoskeletal Disease in Patients with Haemophilia: Results from an Expert Consensus. Blood Coagulation &amp; Fibrinolysis, 29, 509-520.  
https://doi.org/10.1097/MBC.0000000000000767</mixed-citation></ref><ref id="scirp.98297-ref71"><label>71</label><mixed-citation publication-type="other" xlink:type="simple">Goodfellow, J., Fearn, C.B. and Matthews, J.M. (1967) Iliacus Haematoma. A Common Complication of Haemophilia. The Journal of Bone and Joint Surgery, 49, 748-756. https://doi.org/10.1302/0301-620X.49B4.748</mixed-citation></ref><ref id="scirp.98297-ref72"><label>72</label><mixed-citation publication-type="other" xlink:type="simple">Gomez, K., Klamroth, R., Mahlangu, J., Mancuso, M.E., Mingot, M.E., et al. (2014) Key Issues in Inhibitor Management in Patients with Haemophilia. Blood Transfusion, 12(Suppl 1), s319-s329. https://doi.org/10.2450/2013.0246-12</mixed-citation></ref><ref id="scirp.98297-ref73"><label>73</label><mixed-citation publication-type="other" xlink:type="simple">Negrier, C., Seuser, A., Forsyth, A., Lobet, S., Llinas, A., et al. (2013) The Benefits of Exercise for Patients with Haemophilia and Recommendations for Safe and Effective Physical Activity. Haemophilia, 19, 487-498. https://doi.org/10.1111/hae.12118</mixed-citation></ref><ref id="scirp.98297-ref74"><label>74</label><mixed-citation publication-type="other" xlink:type="simple">Lobet, S., Lambert, C. and Hermans, C. (2016) Stop Only Advising Physical Activity in Adults with Haemophilia... Prescribe It Now! The Role of Exercise Therapy and Nutrition in Chronic Musculoskeletal Diseases. Haemophilia, 22, e554-e556.  
https://doi.org/10.1111/hae.13073</mixed-citation></ref><ref id="scirp.98297-ref75"><label>75</label><mixed-citation publication-type="other" xlink:type="simple">Donoso-úbeda, E., Merono-Gallut, J., López-Pina, J.A. and Cuesta-Barriuso, R. (2018) Safety of Fascial Therapy in Adult Patients with Hemophilic Arthropathy of Ankle. A Cohort Study. Musculoskeletal Science and Practice, 35, 90-94.  
https://doi.org/10.1016/j.msksp.2018.03.003</mixed-citation></ref><ref id="scirp.98297-ref76"><label>76</label><mixed-citation publication-type="other" xlink:type="simple">Donoso-úbeda, E., Merono-Gallut, J., López-Pina, J.A. and Cuesta-Barriuso, R. (2019) Effect of Manual Therapy in Patients with Hemophilia and Ankle Arthropathy: A Randomized Clinical Trial. Clinical Rehabilitation, 34, 111-119.  
https://doi.org/10.1177/0269215519879212</mixed-citation></ref><ref id="scirp.98297-ref77"><label>77</label><mixed-citation publication-type="other" xlink:type="simple">Lobet, S., Detrembleur, C., Lantin, A.C., Haenecour, L. and Hermans, C. (2012) Functional Impact of Custom-Made Foot Orthoses in Patients with Haemophilic Ankle Arthropathy. Haemophilia, 18, e227-e235.  
https://doi.org/10.1111/j.1365-2516.2011.02711.x</mixed-citation></ref><ref id="scirp.98297-ref78"><label>78</label><mixed-citation publication-type="other" xlink:type="simple">World Federation of Hemophilia. https://www.wfh.org/en/page.aspx?pid=492</mixed-citation></ref><ref id="scirp.98297-ref79"><label>79</label><mixed-citation publication-type="other" xlink:type="simple">National Hemophilia Foundation. https://www.hemophilia.org/</mixed-citation></ref><ref id="scirp.98297-ref80"><label>80</label><mixed-citation publication-type="other" xlink:type="simple">European Association for Haemophilia and Allied Disorders. http://eahad.org/</mixed-citation></ref></ref-list></back></article>